セリアック患者におけるダイエット炎症指数の臨床的影響
Arzu Gülseren1, Aslıhan Besparmak2, Neşe Kaya2
1Department of Pediatric Gastroenterology and Hepatology, Kayseri City Education and Research Hospital, Kayseri, Turkey.
Clinical pediatrics
|February 19, 2026
まとめ
セリアック疾患 (CD) の小児の食事による炎症指数 (DII) は,疾患マーカーと貧弱な人体測定値と相関しており,炎症がこれらの患者の栄養に影響することを示しています.
科学分野:
- 小児の栄養について
- 胃腸内科 胃腸内科
- 免疫学 免疫学とは
背景:
- セリアック疾患 (CD) は,グルテン摂取によって引き起こされる自己免疫疾患です.
- 栄養状態と炎症は,小児CDの管理において重要である.
- ダイエット炎症指数 (DII) は,ダイエットの炎症の可能性を定量化します.
研究 の 目的:
- セリアック病 (CD) の小児における食事による炎症指数 (DII) を調査する.
- 小児CDにおけるDIIと臨床マーカーの関係を評価する.
- 食事による炎症がCDの小児のアンソポメトリック測定に与える影響を評価する.
主な方法:
- CDと診断された47人の小児患者 (5~18歳) を対象とした横断的な研究.
- 子ども-DII (c-DII) とエネルギー消費-DII (e-c-DII) のスコアの計算.
- DIIスコア,血清学的マーカー (tTG-IgA,EMA),および人類測定値の間の相関の分析.
主要な成果:
- 平均c-DIIは2.0 ± 1.0で,e-c-DIIは2.7 ± 0.8.8でした.
- c-DII/e-c-DIIとtTG-IgA/EMAの抗体レベルとの間に有意な相関が見られた.
- より高い平均c-DIIは,下腰周長,中腕周長,皮膚折りの厚さ (10パーセント以下) の患者で観察され,統計的に有意であった.
結論:
- c-DIIで測定された食事による炎症は,セリアック病活動の血清学的マーカーと有意に関連しています.
- 食事による炎症性スコアが高くなるCDの子どもは,より貧弱な人類測定値を持つ傾向があります.
- これらの発見は,小児性セリアック病における食事による炎症の可能性と栄養状態の間の実質的な相関を強調しています.
関連する概念動画
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
940
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
940
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.3K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.2K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.2K
01:17Irritable Bowel Syndrome I: Introduction
1.2K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.2K
01:17Chronic Bowel Disorders: Introduction
823
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
823
01:29Inflammatory Bowel Disease IV: Pharmacological Management
817
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
817